Cochrane Abstracts
Ziprasidone versus other atypical antipsychotics for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ziprasidone Versus Other Atypical Antipsychotics for Schizophrenia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia. Accessed 29 September 2023.
Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia. Accessed September 29, 2023.
Ziprasidone versus other atypical antipsychotics for schizophrenia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia
Ziprasidone Versus Other Atypical Antipsychotics for Schizophrenia [Internet]. In: Cochrane Abstracts. [cited 2023 September 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ziprasidone versus other atypical antipsychotics for schizophrenia
ID - 434152
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia
DB - Evidence Central
DP - Unbound Medicine
ER -
